Global and Europe Urinary System Drugs Market - Analysis and Outlook to 2022
This report presents a comprehensive overview of the Urinary System Drugs market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Urinary System Drugs industry.
This report focuses Global and Europe market, including details as following:
Key Players
Urinary System Drugs Market, by Loop diuretics
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Urinary System Drugs industry.
This report focuses Global and Europe market, including details as following:
Key Players
- ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
- AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad
- AREVIPHARMA GMBH DE 01445 Radebeul
- AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai
- AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
- Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure
- BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
- Cambrex Charles City, Inc. US 50616-3466 Charles City
- CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa
- CKD BIO CORPORATION KR 15604 Ansan-si
- Cosma S.p.A. IT 24040 Ciserano
- CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City
- CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat
- EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
- F Hoffmann-La Roche Ltd. CH 4070 Basel
- F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
- FLAMMA S.P.A. IT 24040 Chignolo d'Isola
- G.D. Searle LLC US 10017 New York City
- Gedeon Richter Plc. HU 1103 Budapest
- HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
- HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City
- Industriale Chimica S.R.L. IT 21047 Saronno
- IPCA Laboratories Limited IN 400 067 Mumbai
- Laboratori Alchemia Srl IT 20134 Milano
- MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur
- Micronised SANOFI CHIMIE FR 94250 Gentilly
- Moehs Iberica S.L. ES 08191 Rubi
- MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
- NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad
- OLON S.P.A. IT 20090 Rodano
- North America
- United States
- Canada
- Latin America
- Mexico
- Brazil
- Argentina
- Others
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherland
- Others
- Asia & Pacific
- China
- Japan
- India
- Korea
- Australia
- Southeast Asia
- Indonesia
- Thailand
- Philippines
- Vietnam
- Singapore
- Malaysia
- Others
- Africa & Middle East
- South Africa
- Egypt
- Turkey
- Saudi Arabia
- Iran
- Others
Urinary System Drugs Market, by Loop diuretics
- Furosemide
- Bumetanide
- Bumetanide
- Ethacrynic Acid
- Etozolin
- Muzolimine
- Piretanide
- Ticrynafen
- Torasemide
- Hydrochlorothiazide
- Bendrofluazide
- Hdyroflumethiazide
- Polythiazide
- Trichlormethiazide
- Cyclopenthiazide
- Methyclothiazide
- Cyclothiazide
- Mebutizide
- Quinethazone
- Clopamide
- Chlorthalidone
- Mefruside
- Clofenamide
- Metolazone
- Meticrane
- Xipamide
- Indapamide
- Clorexolone
- Fenquizone
- Amiloride
- Triamterene
- Spironolactone
- Eplerenone
- Canrenoate Potassium
- Canrenone
- Conivaptan
- Mozavaptan
- Tolvaptan
- Demeclocycline
- Urology Surgery
- department of nephropathy
- Liver disease division
- Hospital
- Clinic
- Urology Surgery
- department of nephropathy
- Liver disease division
- Hospital
- Clinic
Global and Europe Urinary System Drugs Market - Analysis and Outlook to 2022
1 MARKET OUTLINE
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Urinary System Drugs Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Urinary System Drugs Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing
1.5.3 Consumer Preference
1.5.4 Behavioral Habits
1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
1.8.1 Development Trend
1.8.2 Research Conclusion
2 GLOBAL URINARY SYSTEM DRUGS PRODUCT OVERVIEW
2.1 Global Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Urinary System Drugs, by Loop diuretics 2012-2017
2.2.1 Global Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
2.2.2 Global Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
2.2.3 Global Urinary System Drugs Price by Loop diuretics 2012-2017
2.2.4 Furosemide
2.2.5 Bumetanide
2.2.6 Bumetanide
2.2.7 Ethacrynic Acid
2.2.8 Etozolin
2.3 Urinary System Drugs, by Thiazide diuretic 2012-2017
2.3.1 Global Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
2.3.2 Global Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
2.3.3 Global Urinary System Drugs Price by Thiazide diuretic 2012-2017
2.3.4 Hydrochlorothiazide
2.3.5 Bendrofluazide
2.3.6 Hdyroflumethiazide
2.3.7 Polythiazide
2.3.8 Trichlormethiazide
2.4 Urinary System Drugs, by Thiazide-like diuretics 2012-2017
2.4.1 Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
2.4.2 Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
2.4.3 Global Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
2.4.4 Quinethazone
2.4.5 Clopamide
2.4.6 Chlorthalidone
2.4.7 Mefruside
2.4.8 Clofenamide
2.5 Urinary System Drugs, by potassium-sparing diuretics 2012-2017
2.5.1 Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
2.5.2 Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
2.5.3 Global Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
2.5.4 Amiloride
2.5.5 Triamterene
2.5.6 Spironolactone
2.5.7 Eplerenone
2.5.8 Canrenoate Potassium
2.6 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
2.6.1 Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
2.6.2 Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
2.6.3 Global Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
2.6.4 Conivaptan
2.6.5 Mozavaptan
2.6.6 Tolvaptan
2.6.7 Demeclocycline
3 EUROPE URINARY SYSTEM DRUGS PRODUCT OVERVIEW
3.1 Europe Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017
3.2 Urinary System Drugs, by Loop diuretics 2012-2017
3.2.1 Europe Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
3.2.2 Europe Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
3.2.3 Europe Urinary System Drugs Price by Loop diuretics 2012-2017
3.2.4 Furosemide
3.2.5 Bumetanide
3.2.6 Bumetanide
3.2.7 Ethacrynic Acid
3.2.8 Etozolin
3.3 Urinary System Drugs, by Thiazide diuretic 2012-2017
3.3.1 Europe Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
3.3.2 Europe Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
3.3.3 Europe Urinary System Drugs Price by Thiazide diuretic 2012-2017
3.3.4 Hydrochlorothiazide
3.3.5 Bendrofluazide
3.3.6 Hdyroflumethiazide
3.3.7 Polythiazide
3.3.8 Trichlormethiazide
3.4 Urinary System Drugs, by Thiazide-like diuretics 2012-2017
3.4.1 Europe Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
3.4.2 Europe Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
3.4.3 Europe Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
3.4.4 Quinethazone
3.4.5 Clopamide
3.4.6 Chlorthalidone
3.4.7 Mefruside
3.4.8 Clofenamide
3.5 Urinary System Drugs, by potassium-sparing diuretics 2012-2017
3.5.1 Europe Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
3.5.2 Europe Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
3.5.3 Europe Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
3.5.4 Amiloride
3.5.5 Triamterene
3.5.6 Spironolactone
3.5.7 Eplerenone
3.5.8 Canrenoate Potassium
3.6 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
3.6.1 Europe Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
3.6.2 Europe Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
3.6.3 Europe Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
3.6.4 Conivaptan
3.6.5 Mozavaptan
3.6.6 Tolvaptan
3.6.7 Demeclocycline
4 URINARY SYSTEM DRUGS TOP COMPANIES PROFILE
4.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
4.1.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
4.1.2 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Urinary System Drugs Models and Performance
4.1.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Business SWOT Analysis and Forecast
4.1.4 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.2 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad
4.2.1 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Company Details and Competitors
4.2.2 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Key Urinary System Drugs Models and Performance
4.2.3 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Business SWOT Analysis and Forecast
4.2.4 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.3 AREVIPHARMA GMBH DE 01445 Radebeul
4.3.1 AREVIPHARMA GMBH DE 01445 Radebeul Company Details and Competitors
4.3.2 AREVIPHARMA GMBH DE 01445 Radebeul Key Urinary System Drugs Models and Performance
4.3.3 AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Business SWOT Analysis and Forecast
4.3.4 AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.4 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai
4.4.1 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Company Details and Competitors
4.4.2 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Key Urinary System Drugs Models and Performance
4.4.3 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Business SWOT Analysis and Forecast
4.4.4 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.5 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
4.5.1 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Company Details and Competitors
4.5.2 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Key Urinary System Drugs Models and Performance
4.5.3 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Business SWOT Analysis and Forecast
4.5.4 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.6 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure
4.6.1 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Company Details and Competitors
4.6.2 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Key Urinary System Drugs Models and Performance
4.6.3 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Business SWOT Analysis and Forecast
4.6.4 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.7 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
4.7.1 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Company Details and Competitors
4.7.2 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Key Urinary System Drugs Models and Performance
4.7.3 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Business SWOT Analysis and Forecast
4.7.4 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.8 Cambrex Charles City, Inc. US 50616-3466 Charles City
4.8.1 Cambrex Charles City, Inc. US 50616-3466 Charles City Company Details and Competitors
4.8.2 Cambrex Charles City, Inc. US 50616-3466 Charles City Key Urinary System Drugs Models and Performance
4.8.3 Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Business SWOT Analysis and Forecast
4.8.4 Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.9 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa
4.9.1 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Company Details and Competitors
4.9.2 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Key Urinary System Drugs Models and Performance
4.9.3 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Business SWOT Analysis and Forecast
4.9.4 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.10 CKD BIO CORPORATION KR 15604 Ansan-si
4.10.1 CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
4.10.2 CKD BIO CORPORATION KR 15604 Ansan-si Key Urinary System Drugs Models and Performance
4.10.3 CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Business SWOT Analysis and Forecast
4.10.4 CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.11 Cosma S.p.A. IT 24040 Ciserano
4.12 CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City
4.13 CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat
4.14 EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
4.15 F Hoffmann-La Roche Ltd. CH 4070 Basel
4.16 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
4.17 FLAMMA S.P.A. IT 24040 Chignolo d'Isola
4.18 G.D. Searle LLC US 10017 New York City
4.19 Gedeon Richter Plc. HU 1103 Budapest
4.20 HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
4.21 HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City
4.22 Industriale Chimica S.R.L. IT 21047 Saronno
4.23 IPCA Laboratories Limited IN 400 067 Mumbai
4.24 Laboratori Alchemia Srl IT 20134 Milano
4.25 MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur
4.26 Micronised SANOFI CHIMIE FR 94250 Gentilly
4.27 Moehs Iberica S.L. ES 08191 Rubi
4.28 MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
4.29 NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad
4.30 OLON S.P.A. IT 20090 Rodano
5 URINARY SYSTEM DRUGS BY REGIONS 2012-2017
5.1 Global Urinary System Drugs Sales Market Share by Regions 2012-2017
5.2 Global Urinary System Drugs Revenue Market Share by Regions 2012-2017
5.3 Global Urinary System Drugs Price by Regions 2012-2017
5.4 North America
5.4.1 United States
5.4.2 Canada
5.5 Latin America
5.5.1 Mexico
5.5.2 Brazil
5.5.3 Argentina
5.5.4 Others in Latin America
5.6 Europe
5.6.1 Germany
5.6.2 United Kingdom
5.6.3 France
5.6.4 Italy
5.6.5 Spain
5.6.6 Russia
5.6.7 Netherland
5.6.8 Others in Europe
5.7 Asia & Pacific
5.7.1 China
5.7.2 Japan
5.7.3 India
5.7.4 Korea
5.7.5 Australia
5.7.6 Southeast Asia
5.7.6.1 Indonesia
5.7.6.2 Thailand
5.7.6.3 Philippines
5.7.6.4 Vietnam
5.7.6.5 Singapore
5.7.6.6 Malaysia
5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
5.8.1 South Africa
5.8.2 Egypt
5.8.3 Turkey
5.8.4 Saudi Arabia
5.8.5 Iran
5.8.6 Others in Africa & Middle East
6 GLOBALURINARY SYSTEM DRUGS BY PLAYERS 2012-2017
6.1 Global Urinary System Drugs Sales Volume Market Share by Brands 2012-2017
6.2 Global Urinary System Drugs Revenue Share by Brands 2012-2017
6.3 Global Top Players Urinary System Drugs Key Product Model and Market Performance
6.4 Global Top Players Urinary System Drugs Key Target Consumers and Market Performance
7 EUROPEURINARY SYSTEM DRUGS BY PLAYERS 2012-2017
7.1 Europe Urinary System Drugs Sales Volume Market Share by Brands 2012-2017
7.2 Europe Urinary System Drugs Revenue Share by Brands 2012-2017
7.3 Europe Top Players Urinary System Drugs Key Product Model and Market Performance
7.4 Europe Top Players Urinary System Drugs Key Target Consumers and Market Performance
8 GLOBAL URINARY SYSTEM DRUGS BY CONSUMER 2012-2017
8.1 Global Urinary System Drugs Sales Market Share by Consumer 2012-2017
8.2 Urology Surgery
8.3 department of nephropathy
8.4 Liver disease division
8.5 Hospital
8.6 Clinic
8.7 Consuming Habit and Preference
9 EUROPE URINARY SYSTEM DRUGS BY CONSUMER 2012-2017
9.1 Europe Urinary System Drugs Sales Market Share by Consumer 2012-2017
9.2 Urology Surgery
9.3 department of nephropathy
9.4 Liver disease division
9.5 Hospital
9.6 Clinic
9.7 Consuming Habit and Preference
10 GLOBAL URINARY SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
10.3 Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
10.4 Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
10.5 Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
10.6 Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
10.7 Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
10.8 Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
11 EUROPE URINARY SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 Europe Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Urinary System Drugs Sales () Forecast by Regions (2017-2022)
11.3 Europe Urinary System Drugs Sales () Forecast by Application (2017-2022)
11.4 Europe Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
11.5 Europe Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
11.6 Europe Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
11.7 Europe Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
11.8 Europe Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
1 MARKET OUTLINE
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Urinary System Drugs Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Urinary System Drugs Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing
1.5.3 Consumer Preference
1.5.4 Behavioral Habits
1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
1.8.1 Development Trend
1.8.2 Research Conclusion
2 GLOBAL URINARY SYSTEM DRUGS PRODUCT OVERVIEW
2.1 Global Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Urinary System Drugs, by Loop diuretics 2012-2017
2.2.1 Global Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
2.2.2 Global Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
2.2.3 Global Urinary System Drugs Price by Loop diuretics 2012-2017
2.2.4 Furosemide
2.2.5 Bumetanide
2.2.6 Bumetanide
2.2.7 Ethacrynic Acid
2.2.8 Etozolin
2.3 Urinary System Drugs, by Thiazide diuretic 2012-2017
2.3.1 Global Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
2.3.2 Global Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
2.3.3 Global Urinary System Drugs Price by Thiazide diuretic 2012-2017
2.3.4 Hydrochlorothiazide
2.3.5 Bendrofluazide
2.3.6 Hdyroflumethiazide
2.3.7 Polythiazide
2.3.8 Trichlormethiazide
2.4 Urinary System Drugs, by Thiazide-like diuretics 2012-2017
2.4.1 Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
2.4.2 Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
2.4.3 Global Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
2.4.4 Quinethazone
2.4.5 Clopamide
2.4.6 Chlorthalidone
2.4.7 Mefruside
2.4.8 Clofenamide
2.5 Urinary System Drugs, by potassium-sparing diuretics 2012-2017
2.5.1 Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
2.5.2 Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
2.5.3 Global Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
2.5.4 Amiloride
2.5.5 Triamterene
2.5.6 Spironolactone
2.5.7 Eplerenone
2.5.8 Canrenoate Potassium
2.6 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
2.6.1 Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
2.6.2 Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
2.6.3 Global Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
2.6.4 Conivaptan
2.6.5 Mozavaptan
2.6.6 Tolvaptan
2.6.7 Demeclocycline
3 EUROPE URINARY SYSTEM DRUGS PRODUCT OVERVIEW
3.1 Europe Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017
3.2 Urinary System Drugs, by Loop diuretics 2012-2017
3.2.1 Europe Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
3.2.2 Europe Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
3.2.3 Europe Urinary System Drugs Price by Loop diuretics 2012-2017
3.2.4 Furosemide
3.2.5 Bumetanide
3.2.6 Bumetanide
3.2.7 Ethacrynic Acid
3.2.8 Etozolin
3.3 Urinary System Drugs, by Thiazide diuretic 2012-2017
3.3.1 Europe Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
3.3.2 Europe Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
3.3.3 Europe Urinary System Drugs Price by Thiazide diuretic 2012-2017
3.3.4 Hydrochlorothiazide
3.3.5 Bendrofluazide
3.3.6 Hdyroflumethiazide
3.3.7 Polythiazide
3.3.8 Trichlormethiazide
3.4 Urinary System Drugs, by Thiazide-like diuretics 2012-2017
3.4.1 Europe Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
3.4.2 Europe Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
3.4.3 Europe Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
3.4.4 Quinethazone
3.4.5 Clopamide
3.4.6 Chlorthalidone
3.4.7 Mefruside
3.4.8 Clofenamide
3.5 Urinary System Drugs, by potassium-sparing diuretics 2012-2017
3.5.1 Europe Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
3.5.2 Europe Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
3.5.3 Europe Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
3.5.4 Amiloride
3.5.5 Triamterene
3.5.6 Spironolactone
3.5.7 Eplerenone
3.5.8 Canrenoate Potassium
3.6 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
3.6.1 Europe Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
3.6.2 Europe Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
3.6.3 Europe Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
3.6.4 Conivaptan
3.6.5 Mozavaptan
3.6.6 Tolvaptan
3.6.7 Demeclocycline
4 URINARY SYSTEM DRUGS TOP COMPANIES PROFILE
4.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
4.1.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
4.1.2 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Urinary System Drugs Models and Performance
4.1.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Business SWOT Analysis and Forecast
4.1.4 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.2 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad
4.2.1 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Company Details and Competitors
4.2.2 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Key Urinary System Drugs Models and Performance
4.2.3 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Business SWOT Analysis and Forecast
4.2.4 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.3 AREVIPHARMA GMBH DE 01445 Radebeul
4.3.1 AREVIPHARMA GMBH DE 01445 Radebeul Company Details and Competitors
4.3.2 AREVIPHARMA GMBH DE 01445 Radebeul Key Urinary System Drugs Models and Performance
4.3.3 AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Business SWOT Analysis and Forecast
4.3.4 AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.4 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai
4.4.1 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Company Details and Competitors
4.4.2 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Key Urinary System Drugs Models and Performance
4.4.3 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Business SWOT Analysis and Forecast
4.4.4 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.5 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
4.5.1 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Company Details and Competitors
4.5.2 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Key Urinary System Drugs Models and Performance
4.5.3 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Business SWOT Analysis and Forecast
4.5.4 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.6 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure
4.6.1 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Company Details and Competitors
4.6.2 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Key Urinary System Drugs Models and Performance
4.6.3 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Business SWOT Analysis and Forecast
4.6.4 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.7 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
4.7.1 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Company Details and Competitors
4.7.2 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Key Urinary System Drugs Models and Performance
4.7.3 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Business SWOT Analysis and Forecast
4.7.4 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.8 Cambrex Charles City, Inc. US 50616-3466 Charles City
4.8.1 Cambrex Charles City, Inc. US 50616-3466 Charles City Company Details and Competitors
4.8.2 Cambrex Charles City, Inc. US 50616-3466 Charles City Key Urinary System Drugs Models and Performance
4.8.3 Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Business SWOT Analysis and Forecast
4.8.4 Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.9 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa
4.9.1 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Company Details and Competitors
4.9.2 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Key Urinary System Drugs Models and Performance
4.9.3 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Business SWOT Analysis and Forecast
4.9.4 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.10 CKD BIO CORPORATION KR 15604 Ansan-si
4.10.1 CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
4.10.2 CKD BIO CORPORATION KR 15604 Ansan-si Key Urinary System Drugs Models and Performance
4.10.3 CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Business SWOT Analysis and Forecast
4.10.4 CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
4.11 Cosma S.p.A. IT 24040 Ciserano
4.12 CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City
4.13 CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat
4.14 EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
4.15 F Hoffmann-La Roche Ltd. CH 4070 Basel
4.16 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
4.17 FLAMMA S.P.A. IT 24040 Chignolo d'Isola
4.18 G.D. Searle LLC US 10017 New York City
4.19 Gedeon Richter Plc. HU 1103 Budapest
4.20 HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
4.21 HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City
4.22 Industriale Chimica S.R.L. IT 21047 Saronno
4.23 IPCA Laboratories Limited IN 400 067 Mumbai
4.24 Laboratori Alchemia Srl IT 20134 Milano
4.25 MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur
4.26 Micronised SANOFI CHIMIE FR 94250 Gentilly
4.27 Moehs Iberica S.L. ES 08191 Rubi
4.28 MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
4.29 NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad
4.30 OLON S.P.A. IT 20090 Rodano
5 URINARY SYSTEM DRUGS BY REGIONS 2012-2017
5.1 Global Urinary System Drugs Sales Market Share by Regions 2012-2017
5.2 Global Urinary System Drugs Revenue Market Share by Regions 2012-2017
5.3 Global Urinary System Drugs Price by Regions 2012-2017
5.4 North America
5.4.1 United States
5.4.2 Canada
5.5 Latin America
5.5.1 Mexico
5.5.2 Brazil
5.5.3 Argentina
5.5.4 Others in Latin America
5.6 Europe
5.6.1 Germany
5.6.2 United Kingdom
5.6.3 France
5.6.4 Italy
5.6.5 Spain
5.6.6 Russia
5.6.7 Netherland
5.6.8 Others in Europe
5.7 Asia & Pacific
5.7.1 China
5.7.2 Japan
5.7.3 India
5.7.4 Korea
5.7.5 Australia
5.7.6 Southeast Asia
5.7.6.1 Indonesia
5.7.6.2 Thailand
5.7.6.3 Philippines
5.7.6.4 Vietnam
5.7.6.5 Singapore
5.7.6.6 Malaysia
5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
5.8.1 South Africa
5.8.2 Egypt
5.8.3 Turkey
5.8.4 Saudi Arabia
5.8.5 Iran
5.8.6 Others in Africa & Middle East
6 GLOBALURINARY SYSTEM DRUGS BY PLAYERS 2012-2017
6.1 Global Urinary System Drugs Sales Volume Market Share by Brands 2012-2017
6.2 Global Urinary System Drugs Revenue Share by Brands 2012-2017
6.3 Global Top Players Urinary System Drugs Key Product Model and Market Performance
6.4 Global Top Players Urinary System Drugs Key Target Consumers and Market Performance
7 EUROPEURINARY SYSTEM DRUGS BY PLAYERS 2012-2017
7.1 Europe Urinary System Drugs Sales Volume Market Share by Brands 2012-2017
7.2 Europe Urinary System Drugs Revenue Share by Brands 2012-2017
7.3 Europe Top Players Urinary System Drugs Key Product Model and Market Performance
7.4 Europe Top Players Urinary System Drugs Key Target Consumers and Market Performance
8 GLOBAL URINARY SYSTEM DRUGS BY CONSUMER 2012-2017
8.1 Global Urinary System Drugs Sales Market Share by Consumer 2012-2017
8.2 Urology Surgery
8.3 department of nephropathy
8.4 Liver disease division
8.5 Hospital
8.6 Clinic
8.7 Consuming Habit and Preference
9 EUROPE URINARY SYSTEM DRUGS BY CONSUMER 2012-2017
9.1 Europe Urinary System Drugs Sales Market Share by Consumer 2012-2017
9.2 Urology Surgery
9.3 department of nephropathy
9.4 Liver disease division
9.5 Hospital
9.6 Clinic
9.7 Consuming Habit and Preference
10 GLOBAL URINARY SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
10.3 Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
10.4 Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
10.5 Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
10.6 Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
10.7 Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
10.8 Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
11 EUROPE URINARY SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 Europe Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Urinary System Drugs Sales () Forecast by Regions (2017-2022)
11.3 Europe Urinary System Drugs Sales () Forecast by Application (2017-2022)
11.4 Europe Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
11.5 Europe Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
11.6 Europe Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
11.7 Europe Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
11.8 Europe Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
LIST OF TABLES AND FIGURES
Table Global Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Price () by Loop diuretics (2012-2017)
Table Top Players of Furosemide Urinary System Drugs Products List
Figure Global Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ethacrynic Acid Urinary System Drugs Products List
Figure Global Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etozolin Urinary System Drugs Products List
Figure Global Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List
Figure Global Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bendrofluazide Urinary System Drugs Products List
Figure Global Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List
Figure Global Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polythiazide Urinary System Drugs Products List
Figure Global Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Trichlormethiazide Urinary System Drugs Products List
Figure Global Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Table Top Players of Quinethazone Urinary System Drugs Products List
Figure Global Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopamide Urinary System Drugs Products List
Figure Global Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorthalidone Urinary System Drugs Products List
Figure Global Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mefruside Urinary System Drugs Products List
Figure Global Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clofenamide Urinary System Drugs Products List
Figure Global Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Table Top Players of Amiloride Urinary System Drugs Products List
Figure Global Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Triamterene Urinary System Drugs Products List
Figure Global Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Spironolactone Urinary System Drugs Products List
Figure Global Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Eplerenone Urinary System Drugs Products List
Figure Global Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Canrenoate Potassium Urinary System Drugs Products List
Figure Global Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Table Top Players of Conivaptan Urinary System Drugs Products List
Figure Global Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mozavaptan Urinary System Drugs Products List
Figure Global Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Tolvaptan Urinary System Drugs Products List
Figure Global Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Demeclocycline Urinary System Drugs Products List
Figure Global Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Europe Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table Europe Urinary System Drugs Price () by Loop diuretics (2012-2017)
Table Top Players of Furosemide Urinary System Drugs Products List
Figure Europe Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Europe Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Europe Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ethacrynic Acid Urinary System Drugs Products List
Figure Europe Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etozolin Urinary System Drugs Products List
Figure Europe Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table Europe Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List
Figure Europe Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bendrofluazide Urinary System Drugs Products List
Figure Europe Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List
Figure Europe Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polythiazide Urinary System Drugs Products List
Figure Europe Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Trichlormethiazide Urinary System Drugs Products List
Figure Europe Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table Europe Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Table Top Players of Quinethazone Urinary System Drugs Products List
Figure Europe Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopamide Urinary System Drugs Products List
Figure Europe Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorthalidone Urinary System Drugs Products List
Figure Europe Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mefruside Urinary System Drugs Products List
Figure Europe Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clofenamide Urinary System Drugs Products List
Figure Europe Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table Europe Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Table Top Players of Amiloride Urinary System Drugs Products List
Figure Europe Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Triamterene Urinary System Drugs Products List
Figure Europe Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Spironolactone Urinary System Drugs Products List
Figure Europe Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Eplerenone Urinary System Drugs Products List
Figure Europe Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Canrenoate Potassium Urinary System Drugs Products List
Figure Europe Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table Europe Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Table Top Players of Conivaptan Urinary System Drugs Products List
Figure Europe Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mozavaptan Urinary System Drugs Products List
Figure Europe Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Tolvaptan Urinary System Drugs Products List
Figure Europe Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Demeclocycline Urinary System Drugs Products List
Figure Europe Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Urinary System Drugs Models and Performance
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Business SWOT Analysis and Forecast
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Company Details and Competitors
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Key Urinary System Drugs Models and Performance
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Business SWOT Analysis and Forecast
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AREVIPHARMA GMBH DE 01445 Radebeul Company Details and Competitors
Table AREVIPHARMA GMBH DE 01445 Radebeul Key Urinary System Drugs Models and Performance
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Business SWOT Analysis and Forecast
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Company Details and Competitors
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Key Urinary System Drugs Models and Performance
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Business SWOT Analysis and Forecast
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Company Details and Competitors
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Key Urinary System Drugs Models and Performance
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Business SWOT Analysis and Forecast
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Company Details and Competitors
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Key Urinary System Drugs Models and Performance
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Business SWOT Analysis and Forecast
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Company Details and Competitors
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Key Urinary System Drugs Models and Performance
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Business SWOT Analysis and Forecast
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Company Details and Competitors
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Key Urinary System Drugs Models and Performance
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Business SWOT Analysis and Forecast
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Company Details and Competitors
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Key Urinary System Drugs Models and Performance
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Business SWOT Analysis and Forecast
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
Table CKD BIO CORPORATION KR 15604 Ansan-si Key Urinary System Drugs Models and Performance
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Business SWOT Analysis and Forecast
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Cosma S.p.A. IT 24040 Ciserano Company Details and Competitors
Table CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City Company Details and Competitors
Table CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat Company Details and Competitors
Table EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano Company Details and Competitors
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Company Details and Competitors
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Company Details and Competitors
Table FLAMMA S.P.A. IT 24040 Chignolo d'Isola Company Details and Competitors
Table G.D. Searle LLC US 10017 New York City Company Details and Competitors
Table Gedeon Richter Plc. HU 1103 Budapest Company Details and Competitors
Table HARMAN FINOCHEM LIMITED IN 400 098 Mumbai Company Details and Competitors
Table HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City Company Details and Competitors
Table Industriale Chimica S.R.L. IT 21047 Saronno Company Details and Competitors
Table IPCA Laboratories Limited IN 400 067 Mumbai Company Details and Competitors
Table Laboratori Alchemia Srl IT 20134 Milano Company Details and Competitors
Table MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur Company Details and Competitors
Table Micronised SANOFI CHIMIE FR 94250 Gentilly Company Details and Competitors
Table Moehs Iberica S.L. ES 08191 Rubi Company Details and Competitors
Table MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village Company Details and Competitors
Table NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad Company Details and Competitors
Table OLON S.P.A. IT 20090 Rodano Company Details and Competitors
Table Global Urinary System Drugs Sales () by Regions (2012-2017)
Table Global Urinary System Drugs Sales Share by Regions (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Regions in 2016
Figure Global Urinary System Drugs Sales Market Share by Regions in 2017
Table Global Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Regions (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2016
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2017
Table Global Urinary System Drugs Price () by Regions (2012-2017)
Table North America Urinary System Drugs Sales () by Regions (2012-2017)
Table North America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Latin America Urinary System Drugs Sales () by Regions (2012-2017)
Table Latin America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Regions (2012-2017)
Table Europe Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Urinary System Drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Urinary System Drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales Volume () by Key Players 2012-2017
Table Global Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017
Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2016
Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2017
Table Global Urinary System Drugs Revenue (Million USD) by Key Players 2012-2017
Table Global Urinary System Drugs Revenue Market Share by Key Players 2012-2017
Figure Global Urinary System Drugs Revenue Market Share by Key Players 2016
Figure Global Urinary System Drugs Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Urinary System Drugs Sales Volume () by Key Players 2012-2017
Table Europe Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017
Figure Europe Urinary System Drugs Sales Volume Market Share by Key Players 2016
Figure Europe Urinary System Drugs Sales Volume Market Share by Key Players 2017
Table Europe Urinary System Drugs Revenue (Million USD) by Key Players 2012-2017
Table Europe Urinary System Drugs Revenue Market Share by Key Players 2012-2017
Figure Europe Urinary System Drugs Revenue Market Share by Key Players 2016
Figure Europe Urinary System Drugs Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Urinary System Drugs Sales () by Consumer (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Consumer (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Consumer in 2016
Figure Global Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Consumer (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Consumer (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Consumer in 2016
Figure Europe Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions in 2022
Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by
Table Global Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Price () by Loop diuretics (2012-2017)
Table Top Players of Furosemide Urinary System Drugs Products List
Figure Global Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ethacrynic Acid Urinary System Drugs Products List
Figure Global Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etozolin Urinary System Drugs Products List
Figure Global Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List
Figure Global Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bendrofluazide Urinary System Drugs Products List
Figure Global Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List
Figure Global Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polythiazide Urinary System Drugs Products List
Figure Global Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Trichlormethiazide Urinary System Drugs Products List
Figure Global Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Table Top Players of Quinethazone Urinary System Drugs Products List
Figure Global Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopamide Urinary System Drugs Products List
Figure Global Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorthalidone Urinary System Drugs Products List
Figure Global Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mefruside Urinary System Drugs Products List
Figure Global Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clofenamide Urinary System Drugs Products List
Figure Global Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Table Top Players of Amiloride Urinary System Drugs Products List
Figure Global Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Triamterene Urinary System Drugs Products List
Figure Global Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Spironolactone Urinary System Drugs Products List
Figure Global Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Eplerenone Urinary System Drugs Products List
Figure Global Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Canrenoate Potassium Urinary System Drugs Products List
Figure Global Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Table Top Players of Conivaptan Urinary System Drugs Products List
Figure Global Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mozavaptan Urinary System Drugs Products List
Figure Global Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Tolvaptan Urinary System Drugs Products List
Figure Global Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Demeclocycline Urinary System Drugs Products List
Figure Global Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Europe Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table Europe Urinary System Drugs Price () by Loop diuretics (2012-2017)
Table Top Players of Furosemide Urinary System Drugs Products List
Figure Europe Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Europe Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Europe Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ethacrynic Acid Urinary System Drugs Products List
Figure Europe Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etozolin Urinary System Drugs Products List
Figure Europe Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table Europe Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List
Figure Europe Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bendrofluazide Urinary System Drugs Products List
Figure Europe Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List
Figure Europe Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polythiazide Urinary System Drugs Products List
Figure Europe Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Trichlormethiazide Urinary System Drugs Products List
Figure Europe Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table Europe Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Table Top Players of Quinethazone Urinary System Drugs Products List
Figure Europe Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopamide Urinary System Drugs Products List
Figure Europe Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorthalidone Urinary System Drugs Products List
Figure Europe Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mefruside Urinary System Drugs Products List
Figure Europe Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clofenamide Urinary System Drugs Products List
Figure Europe Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table Europe Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Table Top Players of Amiloride Urinary System Drugs Products List
Figure Europe Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Triamterene Urinary System Drugs Products List
Figure Europe Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Spironolactone Urinary System Drugs Products List
Figure Europe Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Eplerenone Urinary System Drugs Products List
Figure Europe Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Canrenoate Potassium Urinary System Drugs Products List
Figure Europe Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table Europe Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table Europe Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table Europe Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Europe Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table Europe Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Table Top Players of Conivaptan Urinary System Drugs Products List
Figure Europe Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mozavaptan Urinary System Drugs Products List
Figure Europe Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Tolvaptan Urinary System Drugs Products List
Figure Europe Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Demeclocycline Urinary System Drugs Products List
Figure Europe Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Urinary System Drugs Models and Performance
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Business SWOT Analysis and Forecast
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Company Details and Competitors
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Key Urinary System Drugs Models and Performance
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Business SWOT Analysis and Forecast
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AREVIPHARMA GMBH DE 01445 Radebeul Company Details and Competitors
Table AREVIPHARMA GMBH DE 01445 Radebeul Key Urinary System Drugs Models and Performance
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Business SWOT Analysis and Forecast
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Company Details and Competitors
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Key Urinary System Drugs Models and Performance
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Business SWOT Analysis and Forecast
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Company Details and Competitors
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Key Urinary System Drugs Models and Performance
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Business SWOT Analysis and Forecast
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Company Details and Competitors
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Key Urinary System Drugs Models and Performance
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Business SWOT Analysis and Forecast
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Company Details and Competitors
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Key Urinary System Drugs Models and Performance
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Business SWOT Analysis and Forecast
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Company Details and Competitors
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Key Urinary System Drugs Models and Performance
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Business SWOT Analysis and Forecast
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Company Details and Competitors
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Key Urinary System Drugs Models and Performance
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Business SWOT Analysis and Forecast
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
Table CKD BIO CORPORATION KR 15604 Ansan-si Key Urinary System Drugs Models and Performance
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Business SWOT Analysis and Forecast
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Cosma S.p.A. IT 24040 Ciserano Company Details and Competitors
Table CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City Company Details and Competitors
Table CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat Company Details and Competitors
Table EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano Company Details and Competitors
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Company Details and Competitors
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Company Details and Competitors
Table FLAMMA S.P.A. IT 24040 Chignolo d'Isola Company Details and Competitors
Table G.D. Searle LLC US 10017 New York City Company Details and Competitors
Table Gedeon Richter Plc. HU 1103 Budapest Company Details and Competitors
Table HARMAN FINOCHEM LIMITED IN 400 098 Mumbai Company Details and Competitors
Table HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City Company Details and Competitors
Table Industriale Chimica S.R.L. IT 21047 Saronno Company Details and Competitors
Table IPCA Laboratories Limited IN 400 067 Mumbai Company Details and Competitors
Table Laboratori Alchemia Srl IT 20134 Milano Company Details and Competitors
Table MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur Company Details and Competitors
Table Micronised SANOFI CHIMIE FR 94250 Gentilly Company Details and Competitors
Table Moehs Iberica S.L. ES 08191 Rubi Company Details and Competitors
Table MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village Company Details and Competitors
Table NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad Company Details and Competitors
Table OLON S.P.A. IT 20090 Rodano Company Details and Competitors
Table Global Urinary System Drugs Sales () by Regions (2012-2017)
Table Global Urinary System Drugs Sales Share by Regions (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Regions in 2016
Figure Global Urinary System Drugs Sales Market Share by Regions in 2017
Table Global Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Regions (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2016
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2017
Table Global Urinary System Drugs Price () by Regions (2012-2017)
Table North America Urinary System Drugs Sales () by Regions (2012-2017)
Table North America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Latin America Urinary System Drugs Sales () by Regions (2012-2017)
Table Latin America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Regions (2012-2017)
Table Europe Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Urinary System Drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Urinary System Drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales Volume () by Key Players 2012-2017
Table Global Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017
Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2016
Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2017
Table Global Urinary System Drugs Revenue (Million USD) by Key Players 2012-2017
Table Global Urinary System Drugs Revenue Market Share by Key Players 2012-2017
Figure Global Urinary System Drugs Revenue Market Share by Key Players 2016
Figure Global Urinary System Drugs Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Urinary System Drugs Sales Volume () by Key Players 2012-2017
Table Europe Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017
Figure Europe Urinary System Drugs Sales Volume Market Share by Key Players 2016
Figure Europe Urinary System Drugs Sales Volume Market Share by Key Players 2017
Table Europe Urinary System Drugs Revenue (Million USD) by Key Players 2012-2017
Table Europe Urinary System Drugs Revenue Market Share by Key Players 2012-2017
Figure Europe Urinary System Drugs Revenue Market Share by Key Players 2016
Figure Europe Urinary System Drugs Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Urinary System Drugs Sales () by Consumer (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Consumer (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Consumer in 2016
Figure Global Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Consumer (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Consumer (2012-2017)
Figure Europe Urinary System Drugs Sales Market Share by Consumer in 2016
Figure Europe Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Europe Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions in 2022
Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by
